Statistics for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Total visits
| views | |
|---|---|
| Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update | 723 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 38 |
| February 2025 | 64 |
File Visits
| views | |
|---|---|
| Wolff_2018_human.pdf | 3798 |
| java.util.UUID:f8889404-392e-4ce8-be3d-c0c1a7ab3bd9 | 1047 |
| java.util.UUID:dd0b8cea-bf93-4e63-b4e2-bdcd22de8b10 | 574 |
| java.util.UUID:d9f6dcdf-158f-4b48-9371-4304fe12a304 | 6 |
Top country views
| views | |
|---|---|
| United States | 237 |
| China | 54 |
| Germany | 35 |
| Japan | 35 |
| Spain | 26 |
| Canada | 21 |
| Brazil | 18 |
| United Kingdom | 18 |
| Italy | 17 |
| India | 16 |
| Belgium | 9 |
| France | 9 |
| South Korea | 8 |
| Sweden | 8 |
| Austria | 7 |
| Indonesia | 6 |
| Mexico | 6 |
| Portugal | 6 |
| Turkey | 6 |
| Taiwan | 6 |
| Ukraine | 6 |
| Argentina | 5 |
| Australia | 5 |
| Hong Kong SAR China | 5 |
| Switzerland | 4 |
| Saudi Arabia | 4 |
| Colombia | 3 |
| Denmark | 3 |
| Netherlands | 3 |
| Chile | 2 |
| Finland | 2 |
| Lithuania | 2 |
| Morocco | 2 |
| Philippines | 2 |
| Pakistan | 2 |
| Qatar | 2 |
| Romania | 2 |
| Russia | 2 |
| Singapore | 2 |
| Venezuela | 2 |
| Vietnam | 2 |
| Bangladesh | 1 |
| Costa Rica | 1 |
| Czechia | 1 |
| Ecuador | 1 |
| Egypt | 1 |
| Faroe Islands | 1 |
| Greece | 1 |
| Ireland | 1 |
| Israel | 1 |
| Iran | 1 |
| Jordan | 1 |
| Kazakhstan | 1 |
| Malaysia | 1 |
| New Zealand | 1 |
| Poland | 1 |
| Slovakia | 1 |
| Thailand | 1 |
| Yemen | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 51 |
| Houston | 15 |
| Fairfield | 14 |
| Tokyo | 12 |
| Washington | 11 |
| Cambridge | 10 |
| Düsseldorf | 8 |
| Madrid | 8 |
| Barcelona | 7 |
| Jacksonville | 7 |
| Lake Mary | 7 |
| São Paulo | 7 |
| Guangzhou | 6 |
| Shenzhen | 6 |
| Ghent | 5 |
| Jakarta | 5 |
| Kiev | 5 |
| San Diego | 5 |
| Brussels | 4 |
| Chicago | 4 |
| Freiburg im Breisgau | 4 |
| Istanbul | 4 |
| Kanda | 4 |
| New York | 4 |
| Rome | 4 |
| San Francisco | 4 |
| Stockholm | 4 |
| Temple | 4 |
| Toronto | 4 |
| Vienna | 4 |
| Beijing | 3 |
| Bogotá | 3 |
| Buenos Aires | 3 |
| Caldas da Rainha | 3 |
| Charlotte | 3 |
| Chennai | 3 |
| Chiba | 3 |
| Hong Kong | 3 |
| Jinan | 3 |
| Juiz de Fora | 3 |
| Kiez | 3 |
| Madison | 3 |
| Minneapolis | 3 |
| Montague | 3 |
| Montreal | 3 |
| Mumbai | 3 |
| Mérida | 3 |
| Salvador | 3 |
| Seattle | 3 |
| Weil am Rhein | 3 |
| Wuhan | 3 |
| Ann Arbor | 2 |
| Baltimore | 2 |
| Belleville | 2 |
| Berlin | 2 |
| Changzhou | 2 |
| Copenhagen | 2 |
| Dannemois | 2 |
| Doha | 2 |
| Doninos de Salamanca | 2 |
| Esher | 2 |
| Hamburg | 2 |
| Hanover | 2 |
| Harrisburg | 2 |
| Hualien City | 2 |
| Indianapolis | 2 |
| Islamabad | 2 |
| Islington | 2 |
| Kaohsiung City | 2 |
| Longueuil | 2 |
| Los Angeles | 2 |
| Louisville | 2 |
| Nagoya | 2 |
| Ningbo | 2 |
| Oakland | 2 |
| Phoenix | 2 |
| Porto | 2 |
| Providence | 2 |
| Rabat | 2 |
| Riyadh | 2 |
| Salzburg | 2 |
| Scottsdale | 2 |
| Seoul | 2 |
| Shanghai | 2 |
| Singapore | 2 |
| St Louis | 2 |
| Surat | 2 |
| Toulouse | 2 |
| Vilnius | 2 |
| Wuppertal | 2 |
| Abbey Wood | 1 |
| Albuquerque | 1 |
| Almaty | 1 |
| Amman | 1 |
| Amsterdam | 1 |
| Ankara | 1 |
| Aš | 1 |
| Bangkok | 1 |
| Banjarmasin | 1 |
| Beersheba | 1 |